New York, NY, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Human Microbiome Market by Product (Probiotics, Prebiotics, Medical Foods, Supplements, and Others), by Application (Therapeutics and Diagnostics) and by Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, Cancer, and Other Diseases): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024”. According to the report, global human microbiome market was valued at approximately USD 721.63 million in 2017 and is expected to generate revenue of around USD 1,365.49 million by the end of 2024, growing at a CAGR of around 9.40% between 2018 and 2024.
The human microbiome is the genetic material of microbes such as bacteria, protozoa, viruses, and fungi which are present in or on a human body. The ratio of the number of the microbes and human cells is approximately 10:1. The bacteria in the microbiome helps to regulate our immune system, digest our food, protect against other bacteria, and produce vitamins which are necessary for body functioning. Due to these various benefits provided by human microbiome, there is an increase in the demand for global human microbiome market.
Browse through 54 Tables & 30 Figures spread over 110 Pages and in-depth TOC on “Global Human Microbiome Market Size: Analysis and Forecast, 2017 – 2024”.
Request Free Sample Report of Global Human Microbiome Market Report @ https://www.zionmarketresearch.com/sample/human-microbiome-market
Human microbiome market is segmented based on the product, application, and disease type. Based on products, the human microbiome market is further segmented into prebiotics, probiotics, medical foods, supplements, & others. Probiotics segment is anticipated to dominate the product segment of the human microbiome market. The growth in awareness about beneficial properties such as improvement in digestion helps in weight loss, reduction in risk of heart disease, etc. of probiotics is expected to fuel the growth of the probiotics segment.
Based on application, the human microbiome market is further segmented into therapeutics application & diagnostics application. The increase in the need for reliable & precise medicines and increase in research yielding new applications and usage of the human microbiome is expected to fuel the growth of the therapeutic market. The human microbiome market is thus projected to incline towards therapeutic applications in near future.
Download Free Report Brochure: https://www.zionmarketresearch.com/requestbrochure/human-microbiome-market
The disease type segment is further segmented into obesity, diabetes, an autoimmune disorder, metabolic & gastrointestinal disorders, cancer, & other diseases. Metabolic & gastrointestinal diseases segment is expected to dominate the market in the forecast period. The rise in awareness about the use of human microbiome in the treatment of metabolic & gastrointestinal diseases is expected to fuel the growth of the segment in the disease type segment.
North America is likely to dominate the global market of human microbiome in the forecast period. North America accounted for approximately 32% of the total global human microbiome market in 2018. The U.S. is expected to dominate the North American region. Increase in the number of ongoing clinical trials and early adoption of recently developed technologies is expected to fuel the growth of the human microbiome market. According to the CDC, approximately 8 million patients in the U.S. experience first occurrence of CDI (Clostridium Difficile Infection) per year and approximately 1.1 million are affected by recurrent CDI per year. The success in clinical trials of the use of transplantation of fecal microbiota acted as a starting point for companies to venture into the microbiome-based therapeutics.
Request a Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/human-microbiome-market
North America is expected to be followed by Europe in the forecast period. The increase in the number of an aging population due to which there is an increase in the disease & disorder is further fueling the growth of the European human microbiome market. Also, the increase in the prevalence of lifestyle-related diseases, and awareness about staying fit and healthy is expected to fuel the growth of the human microbiome market in the Europe region.
In the forecast period, Asia Pacific is expected to show the highest growth and also highest CAGR. Surfacing of various initiatives for development of human microbiome in Asia Pacific countries such as China, Japan, & India and increase in government funding for research in precision medicine in the same countries is anticipated to stimulate the growth of the Asia Pacific region. The rise in the number of initiative that aims to optimize the method for the studying the effect of the gut microbiome on human health through various protocols and procedures and rapid development in the research infrastructure is also expected to increase the demand for the market in Asia Pacific region. The rise in interest of investing in Asia Pacific region by various major companies is also expected to fuel the growth of the human microbiome market.
Browse the full "Human Microbiome Market by Product (Probiotics, Prebiotics, Medical Foods, Supplements, and Others), by Application (Therapeutics and Diagnostics) and by Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, Cancer, and Other Diseases): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024" report at https://www.zionmarketresearch.com/report/human-microbiome-market
Latin America is expected to show rapid growth in the forecast period as compared to the Middle East & Africa. The rise in awareness about the use of the human microbiome is mainly anticipated to fuel the growth of human microbiome market in these regions. The development in healthcare & research infrastructure is also anticipated to increase the demand of human microbiome market in the forecast period.
The main players involved in the global human microbiome market are AOBiome LLC, Second Genome, Seres Therapeutics, Osel, Inc., Metabiomics Corp., uBiome, Inc., Rebiotix, Inc., Enterome Biosciences, Vedanta Biosciences, and Synthetic Biologics, Inc. The major companies focus on developing new solutions & products by entering into partnership or through acquisition. In 2016, Monsanto collaborated with Second Genome to use microbiome technology platform to accelerate protein discovery.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/human-microbiome-market
This report segments the global human microbiome market as follows:
Global Human Microbiome Market: Product Segment Analysis
Global Human Microbiome Market: Application Segment Analysis
Global Human Microbiome Market: Disease Type Segment Analysis
Global Human Microbiome Market: Regional Segment Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651